-
FDA approves generic version of Merck's Elestat ophthalmic solution
ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo and PharmaForce/Luitpold Pharmaceuticals for treating eye allergies, Perrigo said.
The FDA approved epinastine hydrochloride ophthalmic solution in the 0.05% strength. The drug is a generic version of Merck's Elestat, used to treat ocular itching related to allergic conjunctivitis.
Annual sales for the branded version before the appearance of generics on the market were $30 million, according to Wolters Kluwer.
-
P&G and Teva's joint venture, PGT Healthcare, to form new OTC force
CINCINNATI — Procter & Gamble on Thursday announced the creation of a new partnership and joint venture with Teva Pharmaceutical Industries to be named PGT Healthcare.
“This unique and transformational partnership creates one of the broadest and deepest [over-the-counter] product portfolios and geographic footprints in the industry,” Teva president and CEO Shlomo Yanai said. “Each company’s leading brands will experience tremendous growth by combining our strengths. We will be better together.”